The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.
Robert H Dworkin; Alec B O'Connor; Joseph Audette; Ralf Baron; Geoffrey K Gourlay; Maija L Haanpää; Joel L Kent; Elliot J Krane; Alyssa A Lebel; Robert M Levy; et al. (Profiled Author: Srinivasa Raja)
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, NY 14642, USA. firstname.lastname@example.org
Mayo Clinic proceedings. Mayo Clinic 2010;85(3 Suppl):S3-14.
The Neuropathic Pain Special Interest Group of the International Association for the Study of Pain recently sponsored the development of evidence-based guidelines for the pharmacological treatment of neuropathic pain. Tricyclic antidepressants, dual reuptake inhibitors of serotonin and norepinephrine, calcium channel alpha(2)-delta ligands (ie, gabapentin and pregabalin), and topical lidocaine were recommended as first-line treatment options on the basis of the results of randomized clinical trials. Opioid analgesics and tramadol were recommended as second-line treatments that can be considered for first-line use in certain clinical circumstances. Results of several recent clinical trials have become available since the development of these guidelines. These studies have examined botulinum toxin, high-concentration capsaicin patch, lacosamide, selective serotonin reuptake inhibitors, and combination therapies in various neuropathic pain conditions. The increasing number of negative clinical trials of pharmacological treatments for neuropathic pain and ambiguities in the interpretation of these negative trials must also be considered in developing treatment guidelines. The objectives of the current article are to review the Neuropathic Pain Special Interest Group guidelines for the pharmacological management of neuropathic pain and to provide a brief overview of these recent studies.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Spencer S Liu; Christopher L WuAnesthesia and analgesia 2007;105(3):789-808.
Charles E Argoff; Misha-Miroslav Backonja; Miles J Belgrade; Gary J Bennett; Michael R Clark; B Eliot Cole; David A Fishbain; Gordon A Irving; Bill H McCarberg; Michael J McLeanMayo Clinic proceedings. Mayo Clinic 2006;81(4 Suppl):S12-25.
S Swaroop Vedula; Palko S Goldman; Ilyas J Rona; Thomas M Greene; Kay DickersinTrials 2012;13():136.
Appears in this Publication
Author of this Publication